Podcasts about medical marijuana inc

A case in which the Court will decide whether economic harms resulting from personal injuries are injuries to “business or property by reason of” the defendant's acts for purposes of a civil treble-damages action under the Racketeer Influenced and Corrupt Organizations (RICO) Act.

Medical Marijuana, Inc. v. Horn | 10/15/24 | Docket #: 23-365

The video features an interview with Dr. Stuart Titus, a cannabis industry expert, at the Emerald Conference in San Diego. Dr. Titus discusses his journey into the cannabis space, the development of CBD products, and the importance of cannabinoids for health and wellness. He explains the concept of cannabinoid deficiency, the potential for cannabinoid testing, and the significance of the entourage effect in cannabis products. The conversation also touches on his current work with Medical Marijuana Inc. and his upcoming trip to Japan to discuss hemp agriculture. Enjoy exploring the incredible journey of the cannabis and CBD industry, particularly how humanitarian efforts and children's health have played a pivotal role in its evolution. Many individuals have seen remarkable benefits for their children dealing with autism, ADD, ADHD, and other conditions through the use of CBD products. These success stories underscore the potential of CBD and cannabis to make a profound difference in people's lives."

On todays show Victoria breaks down the case of Medical Marijuana Inc. V Horn where James Dwayne and Glenn discover What RICO is all about and come to some puzzling conclusions don't miss it! 

Raúl Elizalde Garza es abogado y empresario mexicano. Actualmente es CEO de HempMeds, compañía pionera en la comercialización de productos de CBD y otros cannabinoides extraídos del hemp en Estados Unidos y Latinoamérica. Inició como activista a favor del uso del cannabis en 2013, debido al padecimiento de su pequeña hija Graciela Elizalde, quien padece del síndrome Lennox Gastaut y tenía hasta 400 convulsiones diarias que no pudieron ser tratadas con medicamentos convencionales en 2013.El día de hoy hablamos sobre su historia, de cómo fue que logró legalizar la marihuana medicinal en México y cómo terminó siendo CEO de HempMeds, empresa filial de la compañía estadounidense Medical Marijuana Inc, para México y posteriormente para América Latina. Para conocer más sobre HempMeds te compartimos su página oficial:Página Oficial: HempMeds México Conducido por Moishe Sandler, sígueme en:Página web: Health Coach SandlerFacebook: Moishe SandlerInstagram: @hcsandlerProducido por: @genuinamedia  Distribuido por Genuina Media

New Jersey was the first tri-state domino to fall    As outside General Counsel for the national organization Minorities for Medical Marijuana Inc., Jess Gonzalez Esq.  from   Hiller PC is at the forefront of cannabis legislation.  She joins Kyra Reed to talk about helping her organization and clients navigate the ever changing cannabis landscape.   She explains how she was named one of NJ top 22 Cannabis Raising Stars for her effective presentations at municipal, state and federal level on topics such as social justice/social equity, IP protection, cannabis legislation and state cannabis licensing. Produced by PodConxWomen Leading in Cannabis - https://podconx.com/podcasts/women-leading-in-cannabisKyra Reed - https://podconx.com/guests/kyra-reedJess Gonzalez - https://podconx.com/guests/jessica-gonzaleHiller PC - http://www.hillerpc.com/Minorities for Medical Marijuana - https://minorities4medicalmarijuana.org/

Medical Marijuana, Inc. & Kannaway with CEO Blake Schroeder today on Blunt Business with Jorge Hermida only on Cannabis Radio. Our next guest has extensive business experience in the nutrition industry ranging from legal and regulatory insight to overseeing all aspects of global sales, product development, marketing, distribution, and operations. He now oversees the world's first-ever cannabis-derived nutraceutical products, brands, and supply chain. Blake recently stepped into the role of Chairman of the Board and Chief Executive Officer and President of MJNA replacing Stuart Titus. Before the appointment, he handled international market development, financial performance management, product development, rebranding efforts, and operational development of the Company as a whole. We have enjoyed speaking with Stuart over the years here on Cannabis Radio since our inception.Support this podcast at — https://redcircle.com/blunt-business1131/exclusive-contentAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Investor Ideas Potcasts #613, Cannabis News and Stocks on the Move; CEO of Medical Marijuana, Inc. (OTC: $MJNA)

Investor Ideas Potcasts #613, Cannabis News and Stocks on the Move; CEO of Medical Marijuana, Inc. (OTC: $MJNA)

Investor Ideas Potcasts #613, Cannabis News and Stocks on the Move; CEO of Medical Marijuana, Inc. (OTC: $MJNA)

Blake Schroeder is the newly appointed CEO of Medical Marijuana, Inc., a cannabis company with three distinct business units in the non-psychoactive cannabinoid space.

This week we're joined by Dr. Stuart Titus, CEO of Medical Marijuana Inc. - developers and retailers of cannabis-derived products, and the first-ever publicly traded cannabis company in the USA.In this episode, we explore some of the current legislation and regulations governing the cannabis industry in the USA, including the SAFE Banking Act and FDA regulation.About Dr. Stuart TitusDr. Stuart Titus is a veteran of the financial services and medical healthcare industries with over thirty years of combined experience in each discipline. In the investment banking industry, Dr. Titus worked with well-regarded firms including A.G. Becker, Prudential-Bache Securities, and Credit Suisse-First Boston. After leaving Wall Street, Dr. Titus opened and operated his private physiotherapy practice specialising in microcurrent and stem cell therapeutic treatments.Now, Dr. Titus, a 10-year pioneer of the cannabis industry, is the Chief Executive Officer of the first-ever publicly traded cannabis company in the United States, Medical Marijuana, Inc. Dr. Titus has been involved in all aspects of the medical marijuana and industrial hemp industries as he also oversees a robust portfolio of subsidiary and investment companies. Through his leadership, Medical Marijuana, Inc. became the first company to deliver cannabis brands across U.S. state lines and international borders, making hemp-derived cannabidiol (CBD) available across 50 states and in dozens of countries such as Mexico, Brazil, Paraguay, Argentina and many European nations.Dr. Titus is a graduate of Rollins College in Winter Park, Fla., where he majored in Economics and minored in Business Administration. He earned his Ph.D. degree from the Open International University, which is a World Health Organisation (WHO)-chartered affiliate. He holds a Fellowship with the American Academy of Pain Management and clinical association with the American Association of Integrative Medicine. Quotables‘My eyes were opened when all of a sudden I was introduced to the world of CBD' 02:40‘We can see CBD and the non-psychoactive arena taking a larger and larger piece of the overall cannabis pie every year 19:00‘Cannabis means votes' 29:19ResourcesFollow Medical Marijuana Inc. on Twitter: https://twitter.com/mjna_incFollow Medical Marijuana Inc. on LinkedIn: https://www.linkedin.com/company/medical-marijuana-inc-/Read about the FDA's regulation of cannabis-derived products: https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#approved

In this episode, Hall welcomes Dr. Stuart Titus, Chief Executive Officer and President at Medical Marijuana, Inc. Headquartered in Poway, California, Medical Marijuana, Inc. is a cannabis product research and development company. The Company offers various CBD oils and related products such as CBD tinctures, concentrates, beauty products and pet supplements. Medical Marijuana distributes its products to worldwide customers. Stuart, a 10+ year pioneer of the cannabis industry, is the CEO of the first-ever publicly traded cannabis company in the US, Medical Marijuana, Inc. He has been involved in all aspects of the medical marijuana and industrial hemp industries overseeing a robust portfolio of subsidiaries and investments. Through his leadership, Medical Marijuana, Inc. became the first company to deliver cannabis brands across U.S. state lines, and the first to hold import permits for hemp-derived cannabidiol (CBD) in dozens of countries such as Mexico, Brazil, Paraguay, Argentina and many European nations.   He is also a veteran of the financial services and medical healthcare industries with over thirty years of combined experience in each discipline. In the investment banking industry, Stuart worked with well-regarded firms including A.G. Becker, Prudential-Bache Securities, and Credit Suisse-First Boston. Stuart shares with Hall how he sees the industry evolving and some of the challenges startups face. You can visit Medical Marijuana, Inc. at , via LinkedIn at , and via Twitter at .    Stuart can be contacted via email at . Music courtesy of .

Dr. Stuart Titus is the CEO of Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain.

Dr. Stuart Titus, Ph.D., is an industry innovator who has been involved in the growth of many companies in the cannabis industry, and started his relationship with Medical Marijuana Inc. by becoming its seventh investor. Titus’ is also a Wall Street veteran, where he was a bond trader for 11 years. Dr. Titus earned his undergraduate degree at Rollins College, and his Ph.D. from the Open International University.Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career. Dr. Titus developed several prominent cannabis companies, including HempMeds, KannaLife Sciences Inc, and Kannaway, LLC.Titus’ diverse background in both finance and healthcare is the impetus behind his strong passion to help others by supporting the greater cannabis industry. A graduate of Rollins College in Winter Park, Florida, Titus majored in economics and minored in business administration. He got his start on Wall Street where he worked as a bond trader for eleven years, managing a trading and underwriting department as a V.P. for CS First Boston Corp. Titus then went on to earn his PhD from Open International University, an educational organization affiliated with the World Health Organization.Dr. Titus holds a Fellowship with the American Academy of Pain Management and clinical association with the American Association of Integrative Medicine. He practiced as a British Physiotherapist for over fifteen years, running clinics that specialized in integrative pain management and injury rehabilitation, treating over 40,000 patients. His first-hand experience with therapeutic hemp oil products as nutritional supplements led him to Medical Marijuana Inc. and drives him to continue to support the emerging cannabis medical marijuana and industrial hemp industries in the United States and abroad.

How did CBD became a thing?In 2007 the team at Medical Marijuana Inc. embarked on a journey to introduce the benefits of CBD to the world.   Dr. Stuart Titus explains to Dan Humiston all the challenges that they had to overcame to to become one of the world's first CBD manufactures.   In addition to being the first publicly traded cannabis companies (MJNA), he also talks about their expansion into Central America, South America, Europe and Asia.Produced By MJBulls

In this episode, host Heather Wicklein talks with the Founder and CEO of Minorities for Medical Marijuana Inc, Roz McCarthy and New Frontier Data's Chief Knowledge Officer, John Kagia. They discuss how markets and companies are addressing the disparities in minority representation within the cannabis industry. The outline what steps can be taken to ensure equitable representation for minorities as the industry continues to expand across the country.  Contact: Cannaweek@newfrontierdata.com InstagramTwitterwww.newfrontierdata.com

Dr. Titus Ph.D. is the CEO of Medical Marijuana Inc. and Founder of @wearekannaway and is widely recognized as a cannabis industry icon and innovator known for his groundbreaking research of cannabinoids. Dr. Titus is also a Wall Street Veteran, where he traded bonds for 11 years.   We talk about the future of cannabis as medicine, how it will impact business, as well as the environment.   Enjoy the show.

In this episode, Len is joined by Dr. Stuart Titus, President & CEO of Medical Marijuana Inc.  Titus' diverse background in both finance and healthcare is the impetus behind his strong passion to help others by supporting the greater cannabis industry. In this episode From Wall St. to Cannabis Industry Private vs Public Innovation: many firsts in the Cannabis industry Kannaway partnership Giving back  Positive economic impact Recreational use Entrepreneurs in the Cannabis industry  Excited About Concerned About  

Investor Ideas Potcasts, #Cannabis News and Stocks on the Move: Interview with Todd Morrow, President of HempMeds, subsidiary of Medical Marijuana Inc. (OTC: $MJNA)

Investor Ideas Potcasts, #Cannabis News and Stocks on the Move: Interview with Todd Morrow, President of HempMeds, subsidiary of Medical Marijuana Inc. (OTC: $MJNA)

Investor Ideas Potcasts, #Cannabis News and Stocks on the Move: Interview with Todd Morrow, President of HempMeds, subsidiary of Medical Marijuana Inc. (OTC: $MJNA)

On this call Medical Marijuana, Inc. (Pink Sheets: MJNA) CEO Dr. Stuart Titus and COO Blake Schroeder provide updates on the financial and operational performance of the Company in the second quarter of 2019, share recent research and development progress, and discuss where the company is headed for the remainder of the year and in the future. Second Quarter 2019 Financial and Operating Highlights Record revenue of $20.7 million in the second quarter of 2019, a 30.8% increase over the same quarter in 2018; 13 of 14 quarters of sequential revenue growth; Generated $1.4 million of cash from operations, with total cash balance increasing to $5.4 million at quarter end; Gross Profit of $15.4 million in the second quarter of 2019, a 61% increase over the same quarter in 2018; Adjusted EBITDA of $1.5 million in the second quarter of 2019, an increase of 129% over the same quarter in 2018; Cost of Goods Sold decreased as a percentage of sales from 39% in Q2 of 2018 to 26% in Q2 of 2019, resulting in gross profit margins increasing 74% as compared to 60% in Q2 2018; General & Administrative expenses decreased from 21% of sales in Q2 2018 to 16% of sales revenue in Q2 of 2019; Net Ordinary Income for the period was $877,964; compared to a LOSS of $2 million in the same period last year; The Company's CEO Dr. Stuart Titus was chosen as one of 65 speakers to present oral comments at the U.S. Food & Drug Administration (FDA)'s public hearing discussing products containing cannabis-derived compounds; Subsidiary Kannaway® was recognized by Direct Selling News as one of the top revenue-generating direct selling companies on the 2019 DSN Global 100 list; Subsidiary Kannaway®, was named the winner of a Gold Stevie® Award in the Medium Company of the Year – Health Products & Services category in The 17th Annual American Business Awards®; The Company reached a major milestone for long-term stability testing on its flagship THC-free cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-X™); Subsidiary Kannaway® began pre-marketing initiatives in Japan ahead of significant expected growth. "We are excited to continue our tremendous sequential success with the second quarter of 2019 proving to be the largest sales revenue quarter in the history of our Company," said Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc. "As the world continues to become more receptive to learning about the benefits of hemp-derived CBD, we are enthusiastic about being at the forefront of the global cannabis industry which, according to Arcview Market Research, could be worth $57 billion by 2027." Operating Results – Q2 2019 Compared to Q2 2018 Sales for the second quarter of 2019 exceeded $20.6 million, an increase of more than 30% over Q2 2018. Second quarter sales growth reflects the Company's international and domestic expansion into all sales channels, including direct-to-consumer, wholesale and direct selling channels. The Company reported net ordinary income of $877,964 in the second quarter of 2019, compared to a LOSS of $2 million in the second quarter of the prior year. The Company executed on a strategic profitability and sales growth plan that resulted in gross margins increasing from 61% in Q2 of 2018 to 74% in Q2 of 2019 as well as decreased General & Administrative Expenses as they relate to percentage of sales revenue. "We hope that these impressive results excite our valued shareholders and look forward to providing more transparency and accountability moving forward," said Medical Marijuana, Inc. COO Blake Schroeder. "Our number one priority is profitability and we are not only reaching our quarterly goals for this but are surpassing them." Non-GAAP Adjusted EBITDA for the second quarter of 2019 was $1.5 million or 7.4% of net revenue, compared to $0.7 million or 4.2% of net revenue, in the second quarter of 2018. Finally, the Company generated $1.9 million of cash flow,

On this edition of The Cannabis Today Podcast, Steve Blank hosts Dr. Stuart Titus live from the show floor of the CWCB Expo in NYC. Dr. Titus is the President and CEO of America's first publicly traded cannabis company, Medical Marijuana Inc. Follow us on social or visit www.canna-today.com for more.Support the show (http://www.canna-today.com)

Today on Concierge For better living were joined by Dr. Stuart Titus, Ph.D., to speak about the ins and out of the 2018 farm bill just recently passed. is an industry innovator who has been involved in the growth of many companies in the cannabis industry, and started his relationship with Medical Marijuana Inc. by becoming its seventh investor. Titus’ is also a Wall Street veteran, where he was a bond trader for 11 years. Dr. Titus earned his undergraduate degree at Rollins College, and his Ph.D. from the Open International University. Dr. Titus has been involved in the development and investment of several industry-leading cannabis and industrial hemp businesses during his most recent career. Dr. Titus is the co-founder and President of General Hemp, LLC which, with Titus at the helm, developed several prominent cannabis companies, including HempMeds, KannaLife Sciences Inc, and Kannaway, LLC.

This week we will start by discussing a mixed bag of topics included the US Federal Reserves’ likely decision to raise rates this coming week and this Friday’s sell-off in big tech. In our Your Stock, Our Take segment we take a question from a listener about micro-cap stock, Medical Marijuana Inc. (MJNA:OTC-PINK), which is building a portfolio of investments in companies involved with the much hyped marijuana sector – is it a BUY at present? Our star of the week is from KeyStone’s active coverage, Sandvine Corp. (SVC:TSX), a networking equipment company, which jumped 23% this past week after it was subject to a takeover bid. Our dog of the week is New York Stock Exchange listed IDT Corporation (IDT:NYSE), which lost 21% in one day this past week after the company reported revenues grow but the business swung to a loss in its Q3 results which were hit by a charge for a legal settlement.

The Colorado House passes bills to cap home grows and finance cops to bust folks who grow too much cannabis. What's Really Inside Your Cannabis Vape Cartridge? We take a look at the US Sentencing Commission’s 2016 Report released today. We replay a 2015 interview with the CEO of Medical Marijuana Inc, Stu Titus. I review the DEA’s latest reiteration that hemp-derived CBD oil is illegal under federal law.

Today on Concierge For Better Living Doc Rob is joined by Stuart Titus, President and Chief Executive Officer of Medical Marijuana, Inc. Medical Marijuana, Inc. was founded in March 2009 for the purpose of providing business solutions and partnerships to the medical marijuana and related consumer products industry. The company was founded by Bruce Perlowin, who also served as Chief Executive Officer until 2011. Medical Marijuana, Inc. was the first public company to enter the legalized, medical marijuana business.Medical Marijuana, Inc. serves as an investment partner and parent company in several related ventures and subsidiaries, including KannaLife, Real Scientific Hemp Oil (via subsidiary HempMeds), Cibaderm, Cibdex, Dixie Botanicals, and through their Red Dice Holdings partnership, Dixie Elixirs. The company was named by Money magazine as one of the largest in the medical marijuana and hemp field. It was also featured, along with Perlowin, on a 2009 CNBC special program entitled Marijuana Inc.

Today on Concierge For Better Living Doc Rob is joined by Stuart Titus, President and Chief Executive Officer of Medical Marijuana, Inc. Medical Marijuana, Inc. was founded in March 2009 for the purpose of providing business solutions and partnerships to the medical marijuana and related consumer products industry. The company was founded by Bruce Perlowin, who also served as Chief Executive Officer until 2011. Medical Marijuana, Inc. was the first public company to enter the legalized, medical marijuana business. Medical Marijuana, Inc. serves as an investment partner and parent company in several related ventures and subsidiaries, including KannaLife, Real Scientific Hemp Oil (via subsidiary HempMeds), Cibaderm, Cibdex, Dixie Botanicals, and through their Red Dice Holdings partnership, Dixie Elixirs. The company was named by Money magazine as one of the largest in the medical marijuana and hemp field. It was also featured, along with Perlowin, on a 2009 CNBC special program entitled Marijuana Inc.

This week on #PotStockRadio Eric Butz @PotStockEric Ryan Godfrey @ryanmgodfrey and Chris Trace @supergravy welcome Dr. Stuart Titus CEO of Medical Marijuana Inc $MJNA. If you follow pot stocks you probably know that MJNA was the first ever publically traded medical marijuana company and now there are over 300 companies in the space. We'll talk to Dr. Titus about the direction of the company and some questions about the history of Medical Marijuana Inc. as well.   As always any questions or feedback about the show can be directed to eric@potstockradio.com PotStockRadio does not condone or promote the use of any illegal substance. Also, PotStockRadio is for educational and entertainment purposes only!

Medical Marijuana Inc. CEO Stuart Titus Talks CBD, 100 Million Dollar Lawsuit

Medical Marijuana Inc. CEO Stuart Titus Talks CBD, 100 Million Dollar Lawsuit

Nicole Sandler speaks with a listener who's going to jail tomorrow on marijuana charges, Bruce Perlowin-the chairman of Medical Marijuana Inc, and comedian John Fugelsang

Nicole Sandler interviews the CEO of Medical Marijuana Inc., the first publicly traded company in the marijuana industry!

CEO Dr. Stuart Titus of Medical Marijuana Inc. (OTCPink: MJNA), rejoins Stock Day to discuss growth as a diversified Medical Marijuana, CBD, and Hemp company. OTCPink: MJNA # sale and distribution of hemp oil # Cannabidiol # Global CBD Pipeline # Brazil # Mexico # A Company of Firsts # Hemp Meds # Kanna Life # Kanna Way # MPS International # nutraceutical and cosmeceutical # Penny Stocks # pharmaceutical # Wellness Managed Services

CEO Dr. Stuart Titus, with Medical Marijuana, Inc. (MJNA), returns to the show with Everett Jolly and they discuss MJNA's upcoming moves to grow their business in the Medical Marijuana Industry. Visit Http://upticknewswire.com/ for more interviews and the latest penny stock news - We are pleased to share the following UPTICK Network Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Uptick CEO Everett Jolly. Uptick staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services.

CEO Dr. Stuart Titus, with Medical Marijuana, Inc. (MJNA), returns to the show with Everett Jolly and they discuss the 9 ballot initiatives in the upcoming election and their affect on the Medical Marijuana Market. We are pleased to share the following UPTICK Network Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Uptick CEO Everett Jolly. Uptick staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services.

CEO Dr. Stuart Titus, with Medical Marijuana, Inc. (MJNA), returns to the show with Everett Jolly and they discuss upcoming Southern California Cannabis Expo and Exporting products in to Mexico We are pleased to share the following UPTICK Network Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Uptick CEO Everett Jolly. Uptick staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services.

CEO Dr. Stuart Titus, with Medical Marijuana, Inc. (MJNA), returns to the show with Everett Jolly and they discuss the changing outlook on cannabis and their "Real Scientific Hemp Oil" (RSHO) product was approved for use in Brazil. We are pleased to share the following UPTICK Network Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Uptick CEO Everett Jolly. Uptick staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services.

Everett Jolly interviews Dr. Stuart Titus, CEO Medical Marijuana, Inc. (MJNA) about Real Scientific Hemp Oil (RSHO) and exporting their cannabis products from the U.S. Brazil now allows CBD hemp oil for to those with Epilepsy, Parkinson's Disease and Chronic Pain.